EVAX Inc. is the manufacturing and commercialization subsidiary of Enepret Incorporated, which pioneered the reliable, renewable production of triterpene oils, including squalene, and formulation into oil-in-water adjuvants more than 5 years ago. With a multi-million dollar contract from the National Institutes of Health and private investment, EVAX Inc. has now begun GMP manufacturing of triterpene oils and oil-in-water adjuvants.

EVAX is led by pioneers in synthetic biology, veterans in the pharmaceutical manufacturing, adjuvant, and business fields. Our lean team and leadership include over six PhDs, an MD, and experienced entrepreneurs.